Usually described as a splitting or multiple personality disorder, the concept of schizophrenia is not entirely but rather a ...

As per the Brain and Behavior Research Foundation, it combines two compounds called xanomeline and trospium chloride. This is ...

There are as yet no effective drugs for negative symptoms like social withdrawal and lack of motivation. Read more at ...

Those with type 1 schizophrenia typically had more positive symptoms, such as changes in behavior caused by hallucinations or delusions. People diagnosed with type 2 were often more withdrawn and ...

At the Institute of Mental Health (IMH), almost 60 per cent to 70 per cent of patients with schizophrenia make a good ...

It’s also possible to experience a mix of these symptoms. Schizophrenia usually starts in your late teens or young adulthood and is a lifelong condition. If you get catatonia, your episodes may ...

After the Phase II failure of its lead asset from Cerevel, AbbVie is resetting expectations and narrowing the clinical ...

announced positive results from its Phase II NOVA 1 trial of LB-102. The trial evaluated LB-102, a once-daily, orally administered small molecule, as a potential first-in-class benzamide antipsychotic ...

Boehringer said the GPR52 agonists have the potential to tackle the gamut of symptoms in schizophrenia, not only positive symptoms like delusions and hallucinations, which respond to current drugs ...

Using a multi-strain probiotic formulation, researchers conducted a double-blind, randomized, placebo-controlled trial aimed at improving psychiatric and cognitive symptoms, intestinal permeability, ...

Segal Trials, a privately held clinical research network specializing in acute schizophrenia and other psychiatric disorders, ...

With no drugs with different mechanisms for schizophrenia for decades ... profile and ability to broadly target symptoms of schizophrenia, i.e. both positive (delusions and hallucination) symptoms ...